Back to GI Giverny Capital Inc.

NVONVO

Showing 8 of 24 quarters

Position history for GIGiverny Capital Inc.'s holdings in Novo Nordisk A/S

No. Giverny Capital exited its NVO (Novo Nordisk) position in Q2 2026. Its Q1 2026 13F listed 12,400 shares worth $455,700. Giverny Capital first reported NVO in Q3 2020 and held it in 23 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.5M

Total Shares Change

-12,400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$47.34
0
2026-Q1
Unchanged
12,400
0.0%
$455,7000.0%$36.29
0
2025-Q4
Unchanged
12,400
0.0%
$630,9120.0%$48.46
0
2025-Q3
Unchanged
12,400
0.0%
$688,0760.0%$52.85
0
2025-Q2
Unchanged
12,400
0.0%
$855,8480.0%$65.01
0
2025-Q1
Unchanged
12,400
0.0%
$861,0560.0%$65.40
0
2024-Q4
Unchanged
12,400
0.0%
$1.1M0.0%$79.73
0
2024-Q3
Unchanged
12,400
0.0%
$1.5M0.1%$110.37
0

Optional analytics helps us improve. How it’s used